AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . October 2nd, 2000
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV Immunotherapy - Early Antiviral Treatment Primes Immune System to Suppress Viral Levels Without Drugs
HIV Vaccines - AIDSVAX B/E Reported Safe and Highly Immunogenic in Volunteers
AIDS Dementia - Brain Choline Acetyltransferase Levels Reduced in Early Infection
AIDS Therapies - Lymphoproliferative Responses are Measure of Therapeutic Success
AIDS Therapies - Patients Getting HIV Drug Resistance Genotyping Fare Better
AIDS Therapies - Study Evaluates Dosage Adjustments of Amprenavir
Epidemiology - HIV-2 Infection Present in Guinea-Bissau Since the Early 1980s
HIV Vaccines - Scientists Reveal Possible New Target
HIV-Associated Non-Hodgkin's Lymphoma - High-Dose Chemotherapy/Autologous Stem Cell Transplantation Effective
Pathogenesis (HIV-1) - Optimal Immune Function Requires Virus-Specific Cytotoxic T Lymphocyte Responses
Pediatrics - High Rate of Heart-Related Deaths Found in HIV Infected Children
Pharmacoeconomics - Costs of Treating Abnormal Fat Distribution and Metabolic Abnormalities Outlined
AIDS Therapies - Frequently Monitored Patients Show Better Suppression of HIV Viral Load
AIDS Therapies - HIV Drug Candidate Shown Effective in Preclinical Studies
AIDS Therapies - No Difference in Adherence to Once or Twice Daily Dosing Indicated in Survey
AIDS Therapies - Pharmacokinetics Unaffected When Antivirals Used with Selective Reuptake Inhibitors
Etiology - South African Health Minister Questions Cause of AIDS
HIV Vaccines - First MVA Vaccine Cleared for Human Testing
AIDS Therapies - Combination Suppresses Viral Levels in Protease Inhibitor-Naive Patients
AIDS Therapies - Data on Non-Nucleoside Reverse Transcriptase Inhibitor Presented
Diagnostics - Higher RNA Cutoff Needed for HIV-1 Identification in Cerebrospinal Fluid
Drug Resistance - Company Approved to Perform Routine HIV Resistance Testing
HIV Immunotherapy - Interleukin-2 Plus Antiretroviral Therapy Increases CD4+ Levels
HIV Vaccines - Immunotherapy Evaluated in SIV Infected Rhesus Macaque Model
HIV Vaccines - Monoclonal Antibodies Bind Primary Isolate Virions
HIV Vaccines - Remune Addition Announced to Treat Primary HIV Infection
SIV Vaccines - Protective Immunity Induced by Engineered Avirulent Virus
Vaccine Development - HIV and Herpesvirus Vaccines Based on Cloning Viral Envelope Proteins
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
